SLC19A1 and cancer: Given the implications of SLC19A1 in immune modulation and treatment resistance, further exploration of SLC19A1-targeted therapies by integrating clinical samples, molecular biology experiments, and prospective cohorts could lead to improved outcomes for patients facing aggressive cancers resistant to conventional treatments.